Total Payments
$238,280
2024 Payments
$35,177
Companies
37
Transactions
753
Medicare Patients
1,416
Medicare Billing
$238,123
Payment Breakdown by Category
Consulting$113,986 (47.8%)
Other$64,550 (27.1%)
Food & Beverage$33,272 (14.0%)
Travel$26,385 (11.1%)
Education$87.69 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $113,986 | 87 | 47.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,700 | 27 | 20.0% |
| Food and Beverage | $33,272 | 551 | 14.0% |
| Travel and Lodging | $26,385 | 76 | 11.1% |
| Honoraria | $15,600 | 6 | 6.5% |
| Charitable Contribution | $1,250 | 1 | 0.5% |
| Education | $87.69 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $135,517 | 447 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $52,187 | 57 | $0 (2024) |
| ABIOMED | $31,633 | 61 | $0 (2024) |
| Getinge USA Sales, LLC | $5,445 | 5 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $4,572 | 1 | $0 (2021) |
| Medtronic Vascular, Inc. | $1,855 | 7 | $0 (2019) |
| Impulse Dynamics (USA) Inc. | $1,253 | 16 | $0 (2024) |
| CVRx, Inc. | $1,015 | 8 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $810.62 | 25 | $0 (2024) |
| Amgen Inc. | $557.83 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,177 | 84 | Abbott Laboratories ($16,526) |
| 2023 | $17,707 | 105 | AstraZeneca Pharmaceuticals LP ($8,040) |
| 2022 | $12,422 | 96 | Abbott Laboratories ($9,721) |
| 2021 | $58,450 | 88 | AstraZeneca Pharmaceuticals LP ($36,683) |
| 2020 | $12,552 | 39 | AstraZeneca Pharmaceuticals LP ($7,174) |
| 2019 | $38,296 | 116 | Abbott Laboratories ($33,472) |
| 2018 | $19,333 | 89 | Abbott Laboratories ($17,123) |
| 2017 | $44,342 | 136 | Abbott Laboratories ($39,856) |
All Payment Transactions
753 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Heart Failure | ||||||
| 12/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $4,600.00 | General |
| Category: Heart Failure | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: Heart Failure | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| Category: Heart Failure | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: Heart Failure | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: DIABETES | ||||||
| 11/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Heart Failure | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $149.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $36.84 | General |
| Category: Genetic Disease | ||||||
| 10/29/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $119.96 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $84.94 | General |
| Category: Cardiovascular Device | ||||||
| 09/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Heart Failure | ||||||
| 09/21/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $91.69 | General |
| Category: PULMONOLOGY | ||||||
| 09/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Heart Failure | ||||||
| 09/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $223.57 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/17/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Genetic Disease | ||||||
| 09/17/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Genetic Disease | ||||||
| 09/06/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $7.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Heart Failure | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $6,658.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $587.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $67.78 | General |
| Category: Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 288 | 503 | $168,021 | $48,435 |
| 2022 | 6 | 304 | 652 | $220,565 | $59,269 |
| 2021 | 11 | 430 | 798 | $242,133 | $63,587 |
| 2020 | 9 | 394 | 917 | $263,519 | $66,832 |
Total Patients
1,416
Total Services
2,870
Medicare Billing
$238,123
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 194 | $58,588 | $18,406 | 31.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 27 | 60 | $40,329 | $10,362 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 101 | $31,714 | $9,887 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 46 | $10,580 | $3,469 | 32.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 31 | $6,541 | $1,917 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,313 | $1,481 | 27.9% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 13 | 13 | $7,904 | $1,299 | 16.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,812 | $1,263 | 26.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 32 | 35 | $2,240 | $350.48 | 15.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 94 | 274 | $82,748 | $22,400 | 27.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 89 | $59,749 | $15,759 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 124 | $38,936 | $11,960 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 49 | 64 | $14,720 | $5,042 | 34.3% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 21 | 76 | $17,784 | $2,491 | 14.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,796 | $1,484 | 25.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 11 | 13 | $832.00 | $133.05 | 16.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 81 | 226 | $68,252 | $19,140 | 28.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 133 | $41,762 | $13,136 | 31.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 65 | 150 | $31,650 | $8,630 | 27.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 71 | 91 | $20,930 | $6,459 | 30.9% |
| 93505 | Biopsy of the wall dividing the left and right heart | Facility | 2021 | 14 | 25 | $25,075 | $4,624 | 18.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 13 | 15 | $9,810 | $2,711 | 27.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 15 | $8,820 | $2,438 | 27.6% |
| 93451 | Insertion of catheter for diagnostic evaluation of right heart structures | Facility | 2021 | 15 | 17 | $10,336 | $1,837 | 17.8% |
| 93750 | Evaluation of lower heart chamber assist device with physician analysis | Facility | 2021 | 22 | 55 | $12,870 | $1,553 | 12.1% |
About Arvind Bhimaraj, M.D.,
Arvind Bhimaraj, M.D., is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1275864878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arvind Bhimaraj, M.D., has received a total of $238,280 in payments from pharmaceutical and medical device companies, with $35,177 received in 2024. These payments were reported across 753 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($113,986).
As a Medicare-enrolled provider, Bhimaraj has provided services to 1,416 Medicare beneficiaries, totaling 2,870 services with total Medicare billing of $238,123. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Houston, TX
- Active Since 01/20/2010
- Last Updated 10/15/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1275864878
Products in Payments
- CardioMEMS HF System (Device) $80,770
- FARXIGA (Drug) $52,137
- Impella (Device) $31,633
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $16,082
- CARDIOMEMS (Device) $12,748
- Circulatory Support (Device) $9,158
- HeartMate II LVAS (Device) $6,564
- HeartMate 3 Left Ventricular Assist Device (Device) $5,123
- THYMOGLOBULIN (Biological) $4,572
- CARDIOSAVE HYBRID, TYPE B PLUG (Device) $3,332
- HeartMate (Device) $2,414
- HeartMate 3 Left Ventricular Dev (Device) $2,133
- Cardiohelp (Device) $1,600
- Barostim Neo System (Device) $1,015
- Vasoview Hemopro 2 (Device) $645.24
- OPTIMIZER (Device) $596.82
- Optimizer (Device) $595.96
- ONPATTRO (Drug) $576.61
- HeartWare HVAD (Device) $485.72
- XARELTO (Drug) $351.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Cardiovascular Disease $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547